![Christopher Missling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Missling
No open positions remaining
Net worth: 4 M $ as of 30/06/2026
Profile
Christopher U.
Missling worked at Anavex Life Sciences Corp.
from 2013 to 2026 as President, CEO, Secretary, and Director.
Previous roles include Chief Financial Officer at ImmunoGen, Inc., CFO and Senior Vice President-Strategic Operations at Curis, Inc., Head of Financial Planning at Aventis, Inc., and Head of Healthcare Investment Banking at Brimberg & Co. Education includes graduate and doctorate degrees from Ludwig-Maximilians-Universität München, an MBA from WHU-Otto Beisheim School of Management, and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/01/2026 | 15,10,165 ( 1.63% ) | 4 M $ | 30/06/2026 |
Former positions of Christopher Missling
| Companies | Position | End |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Chief Executive Officer | 30/04/2026 |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
Brimberg & Co.
 Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Director of Finance/CFO | - |
| CURIS, INC. | Director of Finance/CFO | - |
Training of Christopher Missling
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WHU-Otto Beisheim School of Management
 WHU-Otto Beisheim School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Christopher Missling
